title: [Magnetotherapy designed to affect cervical sympathetic ganglia for the treatment of patients with primary open-angle glaucoma].
abstract: The traveling magnetic field was used to treat primary open-angle glaucoma. The field was applied to the projection of cervical sympathetic ganglia of the patients. Hemodynamic parameters of posterior short ciliary arteries and central retinal artery were analysed along with visual evoked potentials, visual field limits, and visual acuity. It was shown that magnetotherapy with the use of an AMO-ATOS apparatus produces better clinical results in patients with stage I and II primary open-angle glaucoma compared with medicamentous therapy (intake of trental tablets).
authors.forename: E V
authors.initials: EV
authors.lastname: Veselova
authors.forename: T G
authors.initials: TG
authors.lastname: Kamenskikh
authors.forename: Iu M
authors.initials: IuM
authors.lastname: Raĭgorodkiĭ
authors.forename: I O
authors.initials: IO
authors.lastname: Kolbenev
authors.forename: E S
authors.initials: ES
authors.lastname: Myshkina
mesh_terms: D000368:Aged; D019842:Ciliary Arteries / Q000503:physiopathology; D005260:Female; D005728:Ganglia, Sympathetic; D005902:Glaucoma, Open-Angle / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D055909:Magnetic Field Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage; D012161:Retinal Artery / Q000503:physiopathology; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D014665:Vasodilator Agents; D010431:Pentoxifylline